Skip to main content

Einführung

  • Chapter
  • 13 Accesses

Zusammenfassung

Die Situation der Diagnostik in der gynäkologischen Onkologie, einschließlich die des Mammakarzinoms, spiegelt anschaulich die allgemeinen Probleme in der Krebsbekämpfung wider.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Dalen A van, Favier J, Gastham WN (1984) Erste Erfahrungen mit TPA als Tumormarker bei Ovarialkarzinom. Tumordiagn Ther 5: 20–23

    Google Scholar 

  • Donaldson ES, Nagell JR von, Porsell S, Gay EC (1980) Multiple biochemical markers in patients with gynaecologic malignancies. Cancer 45: 948–953

    Article  PubMed  CAS  Google Scholar 

  • Fuji SJ, Konishi Suzuki J, Okamura H (1985) Analysis of serum lactic dehydrogenase level and its isoenzymes in ovarian dysgerinioma. Gynecol Oncol 22: 65–72

    Article  Google Scholar 

  • Gericke G, Drankowsky D (1979) Die Bedeutung von Tumormarkern für die klinische Onkologie. Med Klin 74: 701–709

    PubMed  CAS  Google Scholar 

  • Halter SA, Faber LD, Pormenter M, Dupont WD (1984) Carcinoembryonic antigen expression and patient survival in carcinoma of the breast. Oncology 41: 297–302

    Article  PubMed  CAS  Google Scholar 

  • Hünermann D (1982) Vergleichende Untersuchungen von 5 Tumormarkern in der ambulanten Tumornachsorge bei Mamma-und Prostatakarzinom. NUC-Compact B:197–203

    Google Scholar 

  • Kleist SV (1984a) Möglichkeiten und Grenzen des Gebrauchs von Tumormarkern. Lab Med 17: 404–406

    Google Scholar 

  • Kleist SV (1984b) News and views in tumor markers. Nuklearmedizin 23:1–3

    Google Scholar 

  • Koch OM, Uhlenbruck G (1983) Plasmaproteine und Akute-Phase-Reaktion als Tumor-marker bei Malignompatienten. Laboratoriumsblätter 30: 29–35

    Google Scholar 

  • Köhler G, Milstein C (1975) Continuous cultures if fused cells secreting antibody of predefined specificity. Nature 256: 495

    Article  PubMed  Google Scholar 

  • Russel DH (1977) Increased polyamine concentrations in the urine of human cancer patients. Nature 233: 144–152

    Google Scholar 

  • Schlegel G, Liethgans M, Eklund G, Björklund B (1981) Correlation between activity in breast cancer and CEA, TPA and eighteen common laboratory procedures and the importance by the combination use of CEA and TPA. Tumordiagnostik 2: 6–11

    Google Scholar 

  • Ziegenbein R (1982) Tumormarker. Neue Aspekte für die Labordiagnostik. Akademieverlag, Berlin

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Elling, D., Pink, V. (1992). Einführung. In: Tumormarker und Immunszintigraphie in der gynäkologischen Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76882-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76882-8_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76883-5

  • Online ISBN: 978-3-642-76882-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics